iShares Health Innovation Active ETF (BMED)

Assets	$7.18M
Expense Ratio	0.55%
PE Ratio	24.56
Shares Out	240,000
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,126
Open	30.32
Previous Close	30.03
Day's Range	30.32 - 30.44
52-Week Low	20.57
52-Week High	30.95
Beta	0.82
Holdings	134
Inception Date	Sep 29, 2020

About BMED

Fund Home Page

The iShares Health Innovation Active ETF (BMED) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NYSEARCA
• Ticker Symbol: BMED
• ETF Provider: BlackRock

Top 10 Holdings

28.16% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	3.39%
Roche Holding AG	ROG	3.29%
Medtronic plc	MDT	3.24%
Exact Sciences Corporation	EXAS	3.02%
Biogen Inc.	BIIB	2.68%
Edwards Lifesciences Corporation	EW	2.66%
Gilead Sciences, Inc.	GILD	2.66%
Abbott Laboratories	ABT	2.61%
Guardant Health, Inc.	GH	2.48%
Natera, Inc.	NTRA	2.12%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 20, 2023	$0.00721	Dec 27, 2023

Performance

BMED had a total return of 22.16% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.38%.